The question 'What is in the blood?' in the MyBody-X context refers to analyzing DNA variants (SNPs) from a blood sample. Such tests typically examine genes like FTO, MC4R, PPARG, ADRB2, APOA2, TCF7L2, and CLOCK, linked to appetite regulation, energy expenditure, and insulin sensitivity. However, the evidence is mixed: while some variants like ADH1B (alcohol metabolism) show strong, reproducible effects (human-strong), most weight-related genes explain less than 1–2% of BMI variance. Clinical utility for personalized diets is unproven; major health organizations do not recommend routine genetic screening for weight management. Moreover, MyBody-X tests are not diagnostic under German law (GenDG) – they provide risk indications, not medical diagnoses. The blood sample thus serves as a source of genetic information, but interpretation requires caution. For complex traits like weight loss or metabolism, predictive value is low. A doctor should always be consulted for specific health concerns.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5519de26ba314ef53100a24a